Case Study #1. Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist.

Slides:

Advertisements

Similar presentations

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Advertisements

Target Study Cardiac resynchronization therapy (CRT) is an established treatment for advanced heart failure symptoms, impaired LV systolic function, and.

Quality Improvement Initiatives. National Service Framework for Coronary Heart Disease-UK Cooperative Cardiovascular Project (CCP)-USA National Registry.

New 2011 SHIFT quality of life substudy Quality of life ( QoL) in heart failure: where do we stand? Therapies that have survival benefits either have a.

CLINICAL DILEMMAS IN HEART FAILURE:

Emerging Concepts in Heart Failure

EMPHASIS-HF Extended Follow-up

Hospitalizations and Healthcare Costs Need for Reduction in Hospitalizations of Patients With HF

Introduction: Alarming Statistics Causes of Death in Prevalent Dialysis Patients,

Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?

Heart Rate, HF Admissions, and Readmissions

A CASE CHALLENGE IN HFrEF:

The Nurse View.

The Latest Data on Oral Prostacyclin Therapy in PAH

Select Topics in Cardiovascular Medicine

PCP Perspectives Clinical Considerations in Hyperkalemia

Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.

Patient Presentation Patient’s Changing Condition Multiple Considerations To Balance.

Cost Effectiveness and Optimal Outcomes in HF

What Has Been Tried and What Is True?

Approaches for Cardiologists in the Era of the Affordable Care Act

Cardiac Biomarkers: Key Takeaways for Use in Heart Failure and Acute Coronary Syndrome.

Heart Failure Prevention: Mission Impossible?

How Can we Improve Outcomes for the Elderly Patient with AML?

Diabetes Increases Risk of CVD

PAH in Adults CHEST Guideline and Expert Panel Report: Grading of Evidence

Patient-Centric Approach to the Management of Spasticity

Treating HFrEF: Challenges Faced

Should SGLT2 Inhibitors Be the Primary Agents for CV Risk Reduction in T2DM?

Treatment Options to Consider

Management Challenges in CLL

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Seizures in the Elderly: Treatment and Special Considerations

Program Overview. Treatment Options for Post-MI patients with LVD – are all ACE Inhibitors Equal?

Contemporary Issues in Psoriasis Care: A Call to Action

Exploring Emerging Treatments for Hyperkalemia

Evaluating New Therapies in HF

The Importance of Getting the Dose Right in HF

Using Heart Rate as a Biomarker in Clinical Practice.

Antihyperglycemic Therapy

Updates in Heart Failure:

Revisiting the Pharmacoeconomics of HF

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

Challenging the Myths in Heart Failure With Reduced Ejection Fraction

CAD and HF Often Coexist

New Strategies to Reduce HF Readmissions

Insulin in Diabetes Management: Effective Patient Selection Is Key

Iron Deficiency in Heart Failure

The Challenge of AF and PCI: Practical Strategies to Improve Outcomes

Improving Adherence to Antiplatelet Therapy After an ACS Event

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

Background. Current Perspectives on the Management of Iron Deficiency in Chronic Heart Failure.

Post-Heart Failure Mortality

Assessing the Burden of Hyperkalemia

Program Goal. Program Goal Disclaimer Overview.

Emilce Trucco et al. JACEP 2018;j.jacep

Optimizing Outcomes for Patients With Systemic Lupus Erythematosus: Key Considerations.

HF-Related Hospitalization and Readmissions

Assessing the Burden of Hyperkalemia

Evaluating Success of Current Treatments for HCM

Championing Evidence-Based Care in Patients With Acute Low Back Pain

Introduction. Welcome to this program, titled De-Escalating Therapy in Epilepsy: A Return to Monotherapy.

Uptitration of Medications in HF: Start Low but Aim High and Stay High

EMPA-REG OUTCOME: Cumulative incidence of the primary outcome

Top Tips in Evidence-Based Care for HFrEF

RAASi Enabling in the Modern Era

Case-Based Look at Hyperkalemia Identification, Diagnosis, and Management.

Multimodal Approaches to Cracking the Code in Low Back Pain

Motor Fluctuations in PD

Diagnosing HFpEF: What Every Cardiologist Needs to Know

Presentation transcript:

Management of Heart Failure With Comorbidities: Challenging Cases for the Cardiologist

Case Study #1

Case Study #1 (cont)

Case Study #1: Three Months Later….

Case Study #1: Is Treatment Appropriate…Other Options?

ESC 2016 Guidelines: Classifications of Heart Failure

TRED-HF: Reduction of EF With Withdrawal of HF Therapies

Case Study #1: Management of Myocardial Infarction -- Post-Event

Management of Polypharmacy Therapy

Case Study #2

Case Study #2 (cont)

Case Study #2 -- Presentation to the Hospital

Case Study #2: How Should This Case Be Handled?

Additional Treatment Considerations: Concerns in Elderly and Frail Patients

Case Study #2: Treatment

Treatment for Hyperkalemia

Management of Diabetes….It Is Not Just an Endocrine Disorder

Case Study #2: Additional Treatment Considerations …Possibly CRT?

Conclusions

Abbreviations

Abbreviations (cont)